Updates from the Exchange

On June 24, the World Health Organization (WHO) released its new Consolidated Guideline on Self-Care Interventions for Health: Sexual and...

The NIH and NICHD have three new funding opportunity announcements pertaining to contraceptive development. Brief descriptions of each...

On July 11, the U.S. Food and Drug Administration (FDA) issued new draft guidance entitled “Establishing Effectiveness and Safety for...

On July 11, 2019, the U.N. Human Rights Council (HRC) adopted a new resolution on “Access to medicines and vaccines in the context of the...

As a young woman in Madagascar studying to become a seamstress, Honorina didn’t want the stress of worrying about unintended pregnancy...

Through July 31, 2019, the Global Health Technologies Coalition will be accepting nominations for the 2019 Innovating for Impact Awards...

The ECHO trial, a randomized controlled trial, found no meaningful difference in risk of HIV acquisition across three contraceptive...

In response to observational studies that suggest a link between DMPA and risk fo HIV acquisition, FHI 360 has developed a modeling tool...

Currently, there are about 15 different types of contraceptive products on the global market. In preparation for Women Deliver, we take...

New contraceptive products have the potential to help women & girls plan the families and lives they desire. Among the 214 million women...

MCI’s 2019 FRA is open for submission. This funding will support research in reversible, non-hormonal male contraceptive discovery and...

YourChoice Therapeutics is attempting to revolutionize birth control options for women & men by developing options that are hormone-free...